Pfizer Inc. (NYSE:PFE) is one of the 13 Best Large Cap Stocks to Buy Right Now. On July 10, Pfizer Inc. (NYSE:PFE) shared ...

Pfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with non-metastatic ...

Results from the Phase III EMBARK trial show that in combination with leuprolide, Xtandi (enzalutamide) demonstrated a ...

Xtandi plus leuprolide improved overall survival in prostate cancer patients in the Phase 3 EMBARK trial, with no new safety ...

Pfizer (PFE) stock in focus as the company with Astellas Pharma (ALPMF) (ALPMY) announce a Phase 3 trial win for their ...

XTANDI: the first and only androgen receptor inhibitor-based regimen to demonstrate overall survival benefit in non-metastatic hormone-sensitive prostate cancer (nmHSPC) with high-risk biochemical ...

Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic ...

The study demonstrated that XTANDI, in combination with androgen deprivation therapy (ADT), reduces the risk of death by 30% in men with metastatic hormone-sensitive prostate cancer.

XTANDI is currently approved in more than 80 countries for various prostate cancer indications. According to the companies, over 1.5 million men with advanced prostate cancer have been treated with ...